Adults with congenital heart disease in Swiss GUCH centers
Part of Genetic & congenital, Heart & circulation clinical trials.
This study is a national registry that collects health information from adults (age 18+) with congenital heart disease. It may help researchers better understand care and outcomes in people treated at specialized Swiss centers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have congenital heart disease (a heart condition you were born with)
- Receive care at a Swiss center that specializes in GUCH (care for adults with congenital heart disease)
- Agree to take part by signing an informed consent form
- If you have trisomy 21, your parent or legal guardian must consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows children with severe heart problems born recently to see how their brain development progresses. It helps doctors understand what support these children might need as they grow.
This study follows women with congenital heart disease during a single, healthy pregnancy. It aims to track how pregnancy affects the heart and overall health in this group.
This study collects information from people with congenital heart disease (a heart problem you're born with) over their entire life to better understand the condition and improve future care.
This study collects and shares anonymous information about adults being considered for a heart transplant because of a congenital (from birth) heart problem or an inherited heart muscle condition. The goal is to better understand these patients and support research that may improve care.
This study surveys adults with congenital heart disease to understand how psychological trauma and resilience affect their health. You would complete online questionnaires about your experiences and coping.
This study looks at how genes may contribute to congenital heart disease. It may help researchers better understand causes and risk in families like yours.
Hear when a new Congenital Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.